<DOC>
	<DOCNO>NCT00102518</DOCNO>
	<brief_summary>The purpose study test long-term safety tolerability aripiprazole adolescent patient schizophrenia , child adolescent patient bipolar I disorder , manic mixed episode .</brief_summary>
	<brief_title>Aripiprazole Open-Label , Safety Tolerability Study</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>Adolescent patient schizophrenia , child adolescent patient bipolar I disorder , manic mixed episode Patients comorbid serious , uncontrolled systemic illness Patients significant risk commit suicide</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>Open Label</keyword>
	<keyword>Aripiprazole</keyword>
	<keyword>Bipolar I Disorder , Manic Mixed Episode</keyword>
</DOC>